What is Barclays's price target for SHC?

Barclays's latest stated price target for Sotera Health Company (SHC) is $22, from its action on Jan 11, 2023.

What is Barclays's rating on SHC?

Barclays rates SHC Overweight, a bullish rating, as of Jan 11, 2023.

When did Barclays last change its view on SHC?

On Jan 11, 2023, Barclays upgrades to Overweight from Underweight, price target $6 to $22.

Barclays SHC price target and rating history

Sotera Health Company (SHC) · Health Care

Barclays rates Sotera Health Company (SHC) Overweight with a $22 price target, as of its latest action on Jan 11, 2023. It has published 5 rating actions on SHC since July 2021, including 1 upgrade and 2 downgrades. Across 4 firms with a SHC price target in the last 12 months, the median target is $22.

Current rating: Overweight
Price target: $22
Median target, all firms: $22
Actions on SHC: 5

Barclays price target on SHC

Barclays price target on SHC, each point a stated target, July 2021 to January 2023.

Every Barclays rating on SHC

Jan 11, 2023
UpgradeBarclays upgrades to Overweight from Underweight, price target $6 to $22
Nov 15, 2022
DowngradeBarclays downgrades to Underweight from Equal Weight, price target $6
Mar 2, 2022
DowngradeBarclays downgrades to Equal-Weight from Overweight, price target $24
Aug 13, 2021
ReiterateBarclays raises its price target to $32 from $30, keeps Overweight
Jul 13, 2021
ReiterateBarclays raises its price target to $30 from $29, keeps Overweight

How other firms rate SHC

Each firm's latest rating and stated target in the last 12 months.

Firm	Rating	Price target	Date
Goldman Sachs	Buy	$20	Jun 5, 2026
Piper Sandler	Overweight	$24	Jan 9, 2026
RBC Capital Markets	Outperform	$24	Jan 9, 2026
William Blair	Outperform		Dec 18, 2025
BMO Capital Markets	Outperform	$19	Nov 13, 2025

Questions about Barclays and SHC

What is Barclays's price target for SHC?: Barclays's latest stated price target for Sotera Health Company (SHC) is $22, from its action on Jan 11, 2023.
What is Barclays's rating on SHC?: Barclays rates SHC Overweight, a bullish rating, as of Jan 11, 2023.
When did Barclays last change its view on SHC?: On Jan 11, 2023, Barclays upgrades to Overweight from Underweight, price target $6 to $22.
How does Barclays's SHC target compare with other analysts?: Across 4 firms with a SHC price target in the last 12 months, the median target is $22.

More SHC rating histories

All Barclays ratings SHC news and filings Every analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.